AxoSim appoints Alif Saleh as CEO
Co-founder and previous CEO Lowry Curley becomes Chief Scientific Officer
Co-founder and previous CEO Lowry Curley becomes Chief Scientific Officer
First BTK inhibitor to show favourable trend in overall survival vs. standard-of-care chemoimmunotherapy in this setting
ALPHA Phase III trial showed first-in-class, oral, Factor D inhibitor as add-on to Ultomiris or Soliris improved haemoglobin levels and reduced anaemia and fatigue
Highly effective preservation solutions ensuring the safety and protection of personal care products
For the treatment of stenotic lesions of arteriovenous fistula in the haemodialysis management of chronic renal failure
Both the Ministries signed MoU for anaemia control among adolescent girls using Ayurveda interventions
The acquisition enriches AstraZeneca’s growing pipeline of cell therapies with GC012F
We are achieving the target of developed India by making our young children healthy today
The project aims at screening the general health condition of the students enrolled in classes 6th to 12th.
India’s First Integrated Ayush Wellness Centre to come up in Guwahati, foundation stone laid
Subscribe To Our Newsletter & Stay Updated